Trademarkia Logo

Canada

C$
ZURBENFI
REGISTERED

on 10 May 2024

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

US

Serial Number

2163281 filed on 1st Feb 2022

Registration Number

TMA1232306 registered on 10th May 2024

Registration expiry Date

10th May 2034

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

ZURBENFI

Trademark usage description

human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary Read More

Classification Information


Class [005]
Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, anti-allergic medications, and vaccines; human pharmaceutical preparations for the relief of pain


Classification kind code

11

Mark Details


Serial Number

2163281

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 190
on 10th May 2024
Registration Pending
Submitted for opposition 55
on 10th May 2024
Registered
Submitted for opposition 42
on 21st Feb 2024
Advertised
Submitted for opposition 26
on 25th Jan 2024
Approved
Submitted for opposition 27
on 25th Jan 2024
Approval Notice Sent
Submitted for opposition 22
on 19th Jan 2024
Search Recorded
Submitted for opposition 287
on 14th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 1st Feb 2022
Filed
Submitted for opposition 1
on 1st Feb 2022
Created
Submitted for opposition 31
on 1st Feb 2022
Formalized